Beta Bionics, Inc.
(NASDAQ: BBNX)
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
30.000
-
(-%)
Range
28.760 - 30.925
(7.53%)
Open
30.410
Previous Close
30.000
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
634,913
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis